Page last updated: 2024-09-04

docetaxel anhydrous and Pancytopenia

docetaxel anhydrous has been researched along with Pancytopenia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Kunthur, A	1

Other Studies

1 other study(ies) available for docetaxel anhydrous and Pancytopenia

Article	Year
A castrate-resistant metastatic prostate cancer patient with severe pancytopenia, successfully treated with docetaxel chemotherapy. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:5 Topics: Aged; Antineoplastic Agents; Docetaxel; Humans; Male; Pancytopenia; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Severity of Illness Index; Treatment Outcome	2020

Article

Year

A castrate-resistant metastatic prostate cancer patient with severe pancytopenia, successfully treated with docetaxel chemotherapy.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:5

Topics: Aged; Antineoplastic Agents; Docetaxel; Humans; Male; Pancytopenia; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Severity of Illness Index; Treatment Outcome

2020